Bulletin
Investor Alert

GlaxoSmithKline PLC ADR

NYS: GSK

GO
/marketstate/country/us

After Hours

GSK
/zigman2/quotes/209463850/composite

$

37.51

Change

-0.24 -0.64%

Volume

Volume 13,307

Apr 16, 2021, 7:51 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209463850/composite

Previous close

$ 37.69

$ 37.75

Change

+0.06 +0.16%

Day low

Day high

$37.62

$37.90

Open
Open: 37.81

52 week low

52 week high

$33.26

$43.18

Open

Market cap

$92.89B

Average volume

6.48M

P/E ratio

12.98

Rev. per Employee

$464,855

EPS

2.91

Dividend

0.64

Div yield

5.30%

Ex dividend date

2/18/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gsk

MarketWatch News on GSK

  1. 2 Biotech Startups Are Searching for Cancer's Hidden Weaknesses

    8:30 a.m. Today

    - Bill Alpert

  2. GSK Will Help Manufacture Novavax's Covid-19 Vaccine for U.K.

    12:53 p.m. March 29, 2021

    - Josh Nathan-Kazis

  3. Lilly, Vir and Glaxo say combined monoclonal antibodies found 70% reduction in high viral load at day 7

    8:33 a.m. March 29, 2021

    - Ciara Linnane

  4. Eli Lilly, Vir and Glaxo announce positive data in Phase 2 trial of COVID antibody treatment

    8:33 a.m. March 29, 2021

    - Ciara Linnane

  5. The FDA Is Clamping Down. What to Know.

    7:16 a.m. March 29, 2021

    - Josh Nathan-Kazis

  6. GSK and Vir Submit Covid-19 Drug for FDA Authorization

    9:49 a.m. March 26, 2021

    - Josh Nathan-Kazis

  7. Glaxo and Vir say data from Phase 3 trial of antibody treatment shows 85% reduction in hospitalization or death

    8:33 a.m. March 26, 2021

    - Ciara Linnane

  8. GlaxoSmithKline and Vir Biotech have submitted EUA request to FDA for COVID antibody treatment

    8:32 a.m. March 26, 2021

    - Ciara Linnane

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gsk

Other News on GSK

  1. Could Vir Biotechnology Be a Millionaire Maker Stock?

    6:00 a.m. April 17, 2021

    - Motley Fool

  2. Why GlaxoSmithKline Stock Jumped Today

    4:24 p.m. April 15, 2021

    - Motley Fool

  3. EMA begins review of GSK/Vir early COVID-19 treatment VIR-7831

    10:53 a.m. April 15, 2021

    - Seeking Alpha

  4. GSK, INO, DELL and COIN among notable premarket gainers

    8:23 a.m. April 15, 2021

    - Seeking Alpha

  5. GlaxoSmithKline discontinues feladilimab trails in cancer

    4:47 a.m. April 15, 2021

    - Seeking Alpha

  6. 2 Cheap Dividend Stocks You Can Buy Right Now

    11:08 a.m. April 14, 2021

    - Motley Fool

  7. Clovis Oncology: Your Keys To Banking Profits

    3:59 a.m. April 13, 2021

    - Seeking Alpha

  8. Zentalis surges on clinical collaboration with GlaxoSmithKline

    11:19 a.m. April 12, 2021

    - Seeking Alpha

  9. GlaxoSmithKline - I'm Not Buying It (Yet)

    8:18 a.m. April 12, 2021

    - Seeking Alpha

  10. 3 Stocks That Could Suffer if Biden Gives In to This Pressure

    6:30 a.m. April 10, 2021

    - Motley Fool

  11. Pfizer Has a Lumpy Growth Story, But It’s a Promising Investment

    2:42 p.m. April 9, 2021

    - InvestorPlace.com

  12. AstraZeneca vaccine woes could derail global vaccination drive

    7:02 a.m. April 8, 2021

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/gsk

Press Releases on GSK

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.